Fundraising FoxShanda Group — Full Portfolio
12 tracked investments · listed companies and verified rows first
Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US
Ryan Dittamore(CEO)in
Co-investorsAngel Physicians FundBeresford VenturesBlack Mountain VentuesCreative Destruction Lab (CDL)Samsung NextSmartGateVC+3 more
Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.
AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US
Will Patrick(CEO)inMatt Ball(CTO)inJonathan Meed(Senior Software Engineer)Satshabad Khalsa(Software Engineer)Andre Castillo(Director of Hardware Operations, Manufacturing and Quality)Fre Tachea(Director of Fermentation)
Co-investorsCompoundDCVC (Data Collective)GRIDS CapitalHemisphere Ventures LLCTeam Builder VenturesThe E14 Fund+20 more
DigiFT is a regulated trading platform that uses decentralized finance to connect users with illiquid financial assets.
Crypto & Web3Fintech
Co-investorsHash GlobalMirana VenturesHashkey CapitalNorth Beta CapitalOffchain LabsSBI Holdings+1 more
Lumus develops geometric reflective waveguide technology for near-eye displays used in augmented reality glasses, aiming for daylight-readable, energy-efficient displays in a normal eyewear form factor.
Deep TechHardwareNew Materials
Co-investorsJerusalem Global VenturesHTC
QualGent builds AI-native quality infrastructure for software testing and verification, enabling enterprises to validate AI-generated code and systems at scale with deterministic confidence.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US
Shivam Agrawal(CEO)inAaron Yu(CTO)in
Co-investorsLeonis CapitalY CombinatorAmino CapitalDarwin Venture Management
-2.png)
Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
BiotechDeep TechHealthtechLongevitySan Francisco, US
Glenn Markov(Founder)inJohn Ramunas(Founder)inWill Olsen(Vice President Of Development)in
Co-investorsAsymmetry VenturesGold Dragon VenturesLifespan Vision VenturesStartupsStartXY Combinator+7 more
Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.
BiotechDeep TechMedical DevicesCampbell, US
Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Founder)inThomas Oxley(Founder)inTom Oxley(Founder)
BoardRahul Sharma(Director)Alex Morgan(Director)in
Co-investorsAlumni VenturesARCH Venture PartnersForepont Capital PartnersID8 InvestmentsIn-Q-TelK2 Global+15 more
Thryve provides a platform that enables partners to improve patient engagement, preventive care, and clinical research through real-world health insights and insurance innovation.
Data & InfrastructureDigital HealthHealthtechBerlin, DE
Friedrich Lämmel(CEO)inJohn Trimpop(CTO)Paul Burggraf(COO)in
Co-investorsCARMA FUNDKickstart InnovationAbstract VenturesDarling VenturesJoyance PartnersOpenspace Ventures+4 more
THRYVE Automation designs and builds custom turnkey automation systems—including robotics, machine vision, material handling, inspection, and packaging—for manufacturers in energy, life sciences, HVAC/filtration, automotive, and consumer products.
Advanced ManufacturingHardwareRoboticsRichmond, US
Co-investorsMcNally CapitalAbstract VenturesDarling VenturesJoyance PartnersOpenspace VenturesPIVOTNORTH+3 more
UploadVR is an online media outlet publishing news, reviews, and coverage of virtual reality and augmented reality products, games, and industry developments.
GamingMedia & EntertainmentSan Francisco, US
William Mason(Director)Taylor Freeman(Executive Officer, Director)Nick Ochoa(Executive Officer, Director)
Co-investorsColopl NextOutpost CapitalPresence CapitalSparkland CapitalThe Venture Reality FundCRCM Ventures+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.